Mersana Therapeutics Inc (MRSN)

NASDAQ
5.11
-0.22(-4.13%)
After Hours
5.01
-0.10(-1.96%)
- Real-time Data
  • Volume:
    947,818
  • Bid/Ask:
    4.95/6.10
  • Day's Range:
    5.11 - 5.44

MRSN Overview

Prev. Close
5.33
Day's Range
5.11-5.44
Revenue
40K
Open
5.25
52 wk Range
4.84-24.24
EPS
-2.14
Volume
947,818
Market Cap
367.47M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
927,449
P/E Ratio
-
Beta
2.4
1-Year Change
-74.23%
Shares Outstanding
71,911,833
Next Earnings Date
Mar 30, 2022
What is your sentiment on Mersana Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Mersana Therapeutics Inc Company Profile

Employees
110

Mersana Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on developing antibody drug conjugates (ADCs). The Company’s platforms include Dolaflexin and Dolasynthen. Its product candidates include upifitamab rilsodotin (UpRi, XMT-1536) and XMT-1592. The Company’s early stage programs include B7-H4-targeted Dolasynthen ADC, XMT-1660, as well as candidates leveraging the Immunosynthen platform. UpRi is an ADC utilizing the Company’s Dolaflexin platform and targeting NaPi2b, which is an antigen broadly expressed in ovarian cancer and non-small cell lung cancer (NSCLC) adenocarcinoma. XMT-1592 uses the Company’s Dolasynthen platform and targets NaPi2b.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • how become the dip is that much today?
    0
    • insider buying $25 by next week
      2
      • skyrocketing today
        2
        • $77
          2
          • only sell
            0
            • Could be one one of the many biotech pump n dumps
              0
              • as per new soon this will be $35. buy if you can.
                0
                • why it grows so much?
                  0
                  • does anyone own this stock?
                    0
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.